xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

698

International consensus statement on rhinosinusitis

1296. Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in pri mary immune deficiency disorders. J Allergy Clin Immunol Pract . 2013;1(6):573-582. 1297. Buehring I, Friedrich B, Schaaf J, Schmidt H, Ahrens P, Zielen S. Chronic sinusitis refractory to standard manage ment in patients with humoral immunodeficiencies. ClinExp Immunol . 1997;109(3):468-472. 1298. Ryan MW. Diseases associated with chronic rhinosinusitis: what is the significance? Curr Opin Otolaryngol Head Neck Surg . 2008;16(3):231-236. 1299. Stokken J, Gupta A, Krakovitz P, Anne S. Rhinosinusitis in children: a comparison of patients requiring surgery for acute complications versus chronic disease. Am J Otolaryngol . 2014;35(5):641-646. 1300. Numa WA, Desai U, Gold DR, Heher KL, Annino DJ. Silent sinus syndrome: a case presentation and comprehensive review of all 84 reported cases. Ann Otol Rhinol Laryngol . 2005;114(9):688-694. 1301. Annamalai S, Kumar NA, Madkour MB, Sivakumar S, Kubba H. An association between acquired epiphora and the signs and symptoms of chronic rhinosinusitis: a prospective case control study. AmJRhinol . 2003;17(2):111-114. 1302. Zainine R, Loukil I, Dhaouadi A, et al. Ophthalmic complica tions of nasosinus mucoceles. J Fr Ophtalmol . 2014;37(2):93-98. 1303. Ajaiyeoba A, Kokong D, Onakoya A. Clinicopathologic, oph thalmic, visual profiles and management of mucoceles in blacks. J Natl Med Assoc . 2006;98(1):63-66. 1304. Kitagawa K, Hayasaka S, Shimizu K, Nagaki Y. Optic neuropa thy produced by a compressed mucocele in an Onodi cell. Am J Ophthalmol . 2003;135(2):253-254. 1305. Loo JL, Looi AL, Seah LL. Visual outcomes in patients with paranasal mucoceles. Ophthal Plast Reconstr Surg . 2009;25(2):126-129. 1306. Cheon YI, Hong SL, Roh HJ, Cho KS. Fungal ball within Onodi cell mucocele causing visual loss. J Craniofac Surg . 2014;25(2):512-514. 1307. Fleissig E, Spierer O, Koren I, Leibovitch I. Blinding orbital apex syndrome due to Onodi cell mucocele. Case Rep Ophthal molMed . 2014;2014:453789. 1308. Yoshida K, Wataya T, Yamagata S. Mucocele in an Onodi cell responsible for acute optic neuropathy. Br J Neurosurg . 2005;19(1):55-56. 1309. Hirabayashi KE, Idowu OO, Kalin-Hajdu E, et al. Invasive fun gal sinusitis: risk factors for visual acuity outcomes and mor tality. Ophthalmic Plast Reconstr Surg . 2019;35(6):535-542. 1310. Scangas GA, Gudis DA, Kennedy DW. The natural history and clinical characteristics of paranasal sinus mucoceles: a clinical review. Int Forum Allergy Rhinol . 2013;3(9):712-717. 1311. Lund VJ. Anatomical considerations in the aetiology of fronto ethmoidal mucoceles. Rhinology . 1987;25(2):83-88. 1312. Eggesbo HB. Radiological imaging of inflammatory lesions in the nasal cavity and paranasal sinuses. Eur Radiol . 2006;16(4):872-888. 1313. Lund VJ, Lloyd G, Savy L, Howard D. Fungal rhinosinusitis. J Laryngol Otol . 2000;114(1):76-80. 1314. Lundgren S, Andersson S, Sennerby L. Spontaneous bone formation in the maxillary sinus after removal of a cyst: coincidence or consequence? Clin Implant Dent Relat Res . 2003;5(2):78-81.

1279. Zhao K, Kim K, Craig J, Palmer J. Using 3D printed sinonasal models to visualize and optimize personalized sinonasal sinus irrigation strategies. Rhinology . 2020;58(3):266-272. 1280. Tas M, Leezenberg JA, Drexhage HA. Beneficial effects of the thymic hormone preparation thymostimulin in patients with defects in cell-mediated immunity and chronic purulent rhinosinusitis. A double-blind cross-over trial on improve ments in monocyte polarization and clinical effects. ClinExp Immunol . 1990;80(3):304-313. 1281. Dalm VA, de Wit H, Drexhage HA. Thymosin alpha 1: a novel therapeutic option for patients with refractory chronic puru lent rhinosinusitis. Ann N Y Acad Sci . 2012;1270:1-7. 1282. Rose MA, Schubert R, Schmitt-Grohe S, Reichenbach J, Zie len S. Immunoglobulins and inflammatory cytokines in nasal secretions in humoral immunodeficiencies. Laryngoscope . 2006;116(2):239-244. 1283. Jamee M, Moniri S, Zaki-Dizaji M, et al. Clinical, immunolog ical, and genetic features in patients with activated PI3K δ syn drome (APDS): a systematic review. Clin Rev Allergy Immunol 2020;59(3):323-333. 1284. Mazza JM, Lin SY. Primary immunodeficiency and recalci trant chronic sinusitis: a systematic review. Int Forum Allergy Rhinol . 2016;6(10):1029-1033. 1285. Lucuab-Fegurgur DL, Gupta S. Comprehensive clinical and immunological features of 62 adult patients with selective pri mary IgM deficiency. Am J Clin Exp Immunol . 2019;8(6):55. 1286. Krivan G, Chernyshova L, Kostyuchenko L, et al. A mul ticentre study on the efficacy, safety and pharmacokinet ics of IqYmune R , a highly purified 10% liquid intravenous immunoglobulin, in patients with primary immune defi ciency. J Clin Immunol . 2017;37(6):539-547. 1287. Nayan S, Alizadehfar R, Desrosiers M. Humoral primary immunodeficiencies in chronic rhinosinusitis. Curr Allergy AsthmaRep . 2015;15(8):46. 1288. Stevens WW, Peters AT. Immunodeficiency in chronic sinusitis: recognition and treatment. Am J Rhinol Allergy . 2015;29(2):115-118. 1289. Chiarella SE, Grammer LC. Immune deficiency in chronic rhinosinusitis: screening and treatment. Expert Rev Clin Immunol . 2017;13(2):117-123. 1290. Papagiannopoulos P, Kuhar HN, Raman A, et al. Under standing the propensity for chronic sinusitis in patients on immunosuppressive therapy. Am J Rhinol Allergy . 2018;32(6):478-484. 1291. Wang CS, Honeybrook A, Chapurin N, Keswani A, Jang DW. Sinusitis in patients on tumor necrosis factor alpha inhibitors. Int Forum Allergy Rhinol . 2017;7(4):380-384. 1292. Miglani A, Divekar RD, Azar A, Rank MA, Lal D. Revision endoscopic sinus surgery rates by chronic rhinosinusitis sub type. Int Forum Allergy Rhinol . 2018;8(9):1047-1051. 1293. Ocampo CJ, Peters AT. Antibody deficiency in chronic rhi nosinusitis: epidemiology and burden of illness. AmJ Rhinol Allergy . 2013;27(1):34-38. 1294. Ryan MW, Brooks EG. Rhinosinusitis and comorbidities. Curr Allergy Asthma Rep . 2010;10(3):188-193. 1295. Ferguson BJ, Otto BA, Pant H. When surgery, antibiotics, and steroids fail to resolve chronic rhinosinusitis. Immunol Allergy Clin North Am . 2009;29(4):719-732.